Advances in the application of human acellular allogenic dermal matrix in immediate breast reconstruction after mastectomy

doi:10.3877/cma.j.issn.1673-9450.2021.02.011

Abstract

Abstract:

Breast reconstruction immediately after breast cancer resection can reshape the shape of the breast, restore the second sexual sign of women, benefit the mental health of patients, and increase their self-confidence as women. Human acellular allogeneic dermal matrix (HADM) is a kind of allogeneic acellular allogenic dermal matrix. HADM is a kind of allogeneic acellular dermal matrix material, and its application in immediate breast reconstruction after mastectomy has a positive effect on postoperative results. The human acellular dermal matrix has a strong regenerative ability, which can provide solid tissue support for breast reconstruction based on implants and improve the cosmetic effect after operation.The types of HADM, advantages of clinical application, postoperative complications and new alternative materials were reviewed.

Key words: Breast neoplasms, Breast implants, Mammaplasty, Human acellular dermal matrix

Qi Tao, Heli Wang, Lei Chen, Dalun Lyu. Advances in the application of human acellular allogenic dermal matrix in immediate breast reconstruction after mastectomy[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2021, 16(02): 147-152.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhssyxfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1673-9450.2021.02.011

https://zhssyxfzz.cma-cmc.com.cn/EN/Y2021/V16/I02/147

References 53

[17]	Rebowe RE, Allred LJ, Nahabedian MY. The Evolution from Subcutaneous to Prepectoral Prosthetic Breast Reconstruction[J]. Plast Reconstr Surg Glob Open, 2018, 6(6): e1797.
[18]	Nahabedian MY. The bioengineered prosthetic breast reconstruction: advancements, evidence, and outcomes. Gland Surg[J]. Gland Surg, 2019, 8(3): 271-282.
[19]	Cuomo R. Submuscular and Pre-Pectoral ADM Assisted Immediate Breast Reconstruction: A Literature Review. Medicina (Kaunas)[J]. Medicina (Kaunas), 2020, 56(6): 256.
[20]	Kim JY, Yang KM, Youn JH, et al. In Vitro Analysis of Histology, Mechanics, and Safety of Radiation-free Pre-hydrated Human Acellular Dermal Matrix[J]. Breast Cancer, 2020, 23(6): 635-646.
[21]	Chauviere MV, Schutter RJ, Steigelman MB, et al. Comparison of AlloDerm and AlloMax tissue incorporation in rats[J]. Ann Plast Surg, 2014, 73(3): 282-285.
[22]	Macadam SA, Lennox PA. Acellular dermal matrices: use in reconstructive and aesthetic breast surgery[J]. Can J Plast Surg, 2012, 20(2): 75-89.
[23]	Leong M, Basu CB, Hicks MJ. Further evidence that human acellular dermal matrix decreases inflammatory marker of capsule formation in implant-based breast reconstruction[J]. Aesthet Surg J, 2015, 35(1): 40-47
[24]	Chopra K, Buckingham B, Matthews J, et al. Acellular dermal matrix reduces capsule formation in two-stage breast reconstruction[J]. Int Wound J, 2017, 14(2): 414-419.
[25]	Wu C, Cipriano J, Osgood G Jr, et al. Human acellular dermal matrix (AlloDerm^®) dimensional changes and stretching in tissue expander/implant breast reconstruction[J]. Plast Reconstr Aesthet Surg, 2013, 66(10): 1376-1381.
[26]	Basu CB, Leong M, Hicks MJ. Acellular cadaveric dermis decreases the inflammatory response in capsule formation in reconstructive breast surgery[J]. Plast Reconstr Surg, 2010, 126(6): 1842-1847.
[27]	Hinchcliff KM, Orbay H, Busse BK, et al. Comparison of two cadaveric acellular dermal matrices for immediate breast reconstruction: A prospective randomized trial[J]. J Plast Reconstr Aesthet Surg, 2017, 70(5): 568-576.
[28]	Loo YL, Kamalathevan P, Ooi PS, et al. Comparing the Outcome of Different Biologically Derived Acellular Dermal Matrices in Implant-based Immediate Breast Reconstruction: A Meta-analysis of the Literatures[J]. Plast Reconstr Surg Glob Open, 2018, 6(3): e1701.
[29]	Ball JF, Sheena Y, Tarek Saleh DM, et al. A direct comparison of porcine (Stratticei™) and bovine (Surgimend™) acellular dermal matrices in implant-based immediate breast reconstruction[J]. J Plast Reconstr Aesthet Surg, 2017, 70(8): 1076-1082.
[30]	Wu LH, Zhang MX, Chen CY, et al. Breast reconstruction with Alloderm Ready to Use: A meta-analysis of nine observational cohorts[J]. Breast, 2018, 39: 89-96.
[31]	Becker S, Saint-Cyr M, Wong C, et al. AlloDerm versus DermaMatrix in immediate expander-based breast reconstruction: a preliminary comparison of complication profiles and material compliance[J]. Plast Reconstr Surg, 2009, 123(1): 1-6.
[32]	Mendenhall SD, Anderson LA, Ying J, et al. The BREASTrial stage I. Outcomes form the time of tissue expander and acellular dermal matrix placement to definitive reconstruction[J]. Plast Reconstr Surg, 2015, 135(1): 29e-42e.
[33]	Athavale SM, Rangarajan S, Dharamsi L, et al. AlloDerm and DermaMatrix implants for parotidectomy reconstruction: a histologic study in the rat model[J]. Head Neck, 2013, 35(2): 242-249.
[34]	Bullocks JM. DermACELL: a novel and biocompatible acellular dermal matrix in tissue expander and implant-based breast reconstruction[J]. Plast Surg, 2014, 37(10): 529-538.
[35]	Wilson HB. New deep dermal ADM incorporates well in case series of complex breast reconstruction patients[J]. Medicine (Baltimore), 2015, 94(21): e745
[36]	Liu DZ, Mathes DW, Neligan PC, et al. Comparison of outcomes using AlloDerm versus FlexHD for implant-based breast reconstruction[J]. Ann Plast Surg, 2014, 72(5): 503-507.
[37]	Paprottka FJ, Krezdorn N, Sorg H, et al. Evaluation of Complication Rates after Breast Surgery Using Acellular Dermal Matrix: Median Follow-Up of Three Years[J]. Plast Surg Int, 2017, 2017: 1283735.
[38]	Hanson SE, Meaike JD, Selber JC, et al. Aseptic Freeze-Dried versus Sterile Wet-Packaged Human Cadaveric Acellular Dermal Matrix in Immediate Tissue Expander Breast Reconstruction: A Propensity Score Analysis[J]. Plast Reconstr Surg, 2018, 141(5): 624e-632e.
[39]	Ferrando PM, Balmativola D, Cambieri I, et al. Glycerolized Reticular Dermis as a New Human Acellular Dermal Matrix: An Exploratory Study[J]. PLoS One, 2016, 11(2): e0149124.
[40]	Breuing KH, Warren SM. Immediate bilateral breast reconstruction with implants and inferolateral AlloDerm slings[J]. Ann Plast Surg, 2005, 55(3): 232-239.
[41]	Butterfield JL. 440 Consecutive immediate, implant-based, single-surgeon breast reconstructions in 281 patients: a comparison of early outcomes and costs between SurgiMend fetal bovine and AlloDerm human cadaveric acellular dermal matrices[J]. Plast Reconstr Surg, 2013, 131(5): 940-951.
[42]	Bindingnavele V, Gaon M, Ota KS, et al. Use of acellular cadaveric dermis and tissue expansion in postmastectomy breast reconstruction[J]. Plast Reconstr Aesthet Surg, 2007, 60(11): 1214-1218.
[43]	Salzberg CA, Ashikari AY, Koch RM, et al. An 8-year experience of direct-to-implant immediate breast reconstruction using human acellular dermal matrix (AlloDerm)[J]. Plast Reconstr Surg, 2011, 127(2): 514-524.
[44]	Lin HJ, Spoerke N, Deveney C, et al. Reconstruction of complex abdominal wall hernias using acellular human dermal matrix: a single institution experience[J]. Am J Surg, 2009, 197(5): 599-603.
[45]	Endress R, Choi MS, Lee GK. Use of fetal bovine acellular dermal xenograft with tissue expansion for staged breast reconstruction[J]. Ann Plast Surg, 2012, 68(4): 338-341.
[46]	Singh N, Reaven NL, Funk SE. Immediate 1-stage vs. tissue expander postmastectomy implant breast reconstructions: a retrospective real-world comparison over 18 months[J]. Plast Reconstr Aesthet Surg, 2012, 65(7): 917-923.
[47]	Verboket RD, Leiblein M, Janko M, et al. From two stages to one: acceleration of the induced membrane (Masquelet) technique using human acellular dermis for the treatment of non-infectious large bone defects[J]. Trauma Emerg Surg, 2020, 46(2): 317-327.
[48]	Chepla KJ, Dagget JR, Soltanian HT. The partial AlloDerm sling: reducing allograft costs associated with breast reconstruction[J]. Plast Reconstr Aesthet Surg, 2012, 65(7): 924-930.
[1]	Veronesi U, Boyle P, Goldhirsch A, et al. Breast cancer[J]. Lancet, 2005, 365(9472): 1727-1741.
[2]	Wörmann B. Breast cancer: basics, screening, diagnostics and treatment[J]. Med Monatsschr Pharm, 2017, 40(2): 55-64.
[3]	Rossi L, Mazzara C, Pagani O. Diagnosis and Treatment of Breast Cancer in Young Women[J]. Curr Treat Options Oncol, 2019, 20(12): 86.
[4]	Mangialardi ML, Salgarello M, Cacciatore P, et al. Complication Rate of Prepectoral Implant-based Breast Reconstruction Using Human Acellular Dermal Matrices[J]. Plast Reconstr Surg Glob Open, 2020, 8(12): e3235.
[5]	Raposio E, Belgrano V, Santi P, et al. Which is the Ideal Breast Size？: Some Social Clues for Plastic Surgeons [J]. Ann Plast Surg, 2016, 76(3): 340-345.
[6]	Margulies IG, Salzberg CA. The use of acellular dermal matrix in breast reconstruction: evolution of techniques over 2 decades[J]. Gland Surg, 2019, 8(1): 3-10.
[7]	Salzberg CA. Nonexpansive immediate breast reconstruction using human acellular tissue matrix graft(AlloDerm)[J]. Ann Plast Surg, 2006, 57(1): 1-5.
[8]	Ibrahim AM, Koolen PG, Ganor O, et al. Does Acellular Dermal Matrix Really Improve Aesthetic Outcome in Tissue Expander/Implant-Based Breast Reconstruction[J]. Aesthetic Plast Surg, 2015, 39(3): 359-368.
[9]	Jansen LA, Macadam SA. The use of AlloDerm in postmastectomy alloplastic breast reconstruction: part I. A systematic review[J]. Plast Reconstr Surg, 127(6): 2232-2244.
[10]	Nahabedian MY. Prosthetic breast reconstruction with acellular dermal matrices: achieving predictability and reproducibility[J]. Plast Reconstr Surg Glob Open, 2016, 4(5): e698.
[11]	Newman MI, Swartz KA, Samson MC, et al. The true incidence of near-term postoperative complications in prosthetic breast reconstruction utilizing human acellular dermal matrices: a meta-analysis[J]. Aesthetic Plast Surg, 2011, 35(1): 100-106.
[12]	Gurunluoglu R, Gurunluoglu A, Williams SA, et al. Current trends in breast reconstruction: survey of American Society of Plastic Surgeons 2010[J]. Ann Plast Surg, 2013, 70(1): 103-110.
[13]	Liu J, Hou J, Li Z, et al. Efficacy of Acellular Dermal Matrix in Capsular Contracture of Implant-Based Breast Reconstruction: A Single-Arm Meta-analysis[J]. Aesthetic Plast Surg, 2020, 44(3): 735-742.
[14]	Negenborn VL, Young-Afat DA, Dikmans RE, et al. Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial[J]. Lancet Oncol, 2018, 19(9): 1205-1214.
[15]	Smith JM, Broyles JM, Guo Y, et al. Human acellular dermis increases surgical site infection and overall complication profile when compared with submuscular breast reconstruction: An updated meta-analysis incorporating new products[J]. Plast Reconstr Aesthet Surg, 2018, 71(11): 1547-1556.
[16]	Venturi ML, Mesbahi AN, Boehmler JH 4th, et al. Evaluating sterile human acellular dermal matrix in immediate expander-based breast reconstruction: a multicenter, prospective, cohort study[J]. Plast Reconstr Surg, 2013, 131(1): 9e-18e.
[49]	Yalanis GC, Nag S, Georgek JR, et al. Mastectomy weight and tissue expander volume predict necrosis and increased costs associated with breast reconstruction[J]. Plast Reconstr Surg Glob Open, 2015, 3(7): e450.
[50]	Selber JC, Wren JH, Garvey PB, et al. Critical Evaluation of Risk Factors and Early Complications in 564 Consecutive Two-Stage Implant-Based Breast Reconstructions Using Acellular Dermal Matrix at a Single Center[J]. Plast Reconstr Surg, 2015, 136(1): 10-20.
[51]	Sahoo S, Ma J, Tastaldi L, et al. Biodegradable hyaluronan hydrogel coatings on acellular dermis grafts-A potential strategy to improve biologic graft durability in hernia repair application[J]. J Biomed Mater Res B Appl Biomater, 2019, 107(8): 2664-2672.
[52]	Tessler O, Reish RG, Maman DY, et al. Beyond biologics: absorbable mesh as a low-cost, low-complication sling for implant-based breast reconstruction[J]. Plast Reconstr Surg, 2014, 133(2): 90e-99e.
[53]	Schulman MR, Lipper J, Skolnik RA. Correction of chest wall deformity after implant-based breast reconstruction using poly-L-lactic acid (Sculptra)[J]. Breast J, 2008, 14(1): 92-96.

Please choose a citation manager

Content to export